it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
OFF DEAL
218 Used Today
OFF DEAL
200 Used Today